Table 4.
Literature review
| Author/reference | Year | No. | Survival |
|---|---|---|---|
| Skinner [5] | 1989 | 43 | 5-year OS 57% |
| Glazer [11] | 1996 | 18 | 5-year OS 57% |
| 5-year CSS 60% | |||
| Moinzadeh [12] | 2004 | 140 | 10-year OS |
| Renal vein 66% | |||
| IVC 29% | |||
| Kim [13] | 2004 | 81 | 3-year CSS |
| Renal vein 36% | |||
| IVC 35% | |||
| T3c 12% | |||
| Lubahn [14] | 2006 | 44 | 5-year OS 56% |
| Ciancio [15] | 2007 | 56 | 2-year PFS 53% |
| Wagner [16] | 2007 | 1192 | Median survival, mo |
| Renal vein: 52 | |||
| IVC below diaphragm: 25.8 | |||
| IVC above diaphragm: 18 | |||
| Kulkarni et al. (Our series) | 2011 | 100 | 5 year survival |
| OS- 63% | |||
| DFS- 55% |
*CSS Cancer Specific Survival, **PFS Progression Free Survival, ***OS Overall Survival, ****DFS Disease Free Survival